Wojciech Golusinski
Overview
Explore the profile of Wojciech Golusinski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
147
Citations
1126
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sobecka-Giel A, Ostrowska K, Golusinski W, Suchorska W, Masternak M, Golusinski P
Sci Rep
. 2025 Feb;
15(1):5830.
PMID: 39966442
Head and Neck Squamous Cell Carcinoma (HNSCC) is the sixth most common cancer worldwide, with approximately 830,000 new cases and 430,000 deaths reported annually. Due to their heterogeneity, these neoplasms...
2.
Szewczyk M, Ostapowicz J, Piotrowski I, Ostrowska K, Suchorska W, Golusinski W
Contemp Oncol (Pozn)
. 2025 Feb;
28(4):291-296.
PMID: 39935755
Introduction: Despite advances in diagnostics and therapy, the 5-year mortality rate of oral squamous cell cancer (OSCC) remains at about 50%. Prognostic molecular biomarkers are not yet approved for clinical...
3.
Cegla P, Currie G, Wroblewska J, Kazmierska J, Cholewinski W, Jagiello I, et al.
Nuklearmedizin
. 2024 Dec;
64(1):22-31.
PMID: 39631755
To determine whether [F]FDG PET/CT and hematological parameters provide supportive data to determine HPV status in HNSCC patients.Retrospective analysis of clinical and diagnostic data from 106 patients with HNSCC: 26.4%...
4.
Loubieres C, Hans S, Lechien J, Ansarin M, Atallah S, Barbut J, et al.
Eur Arch Otorhinolaryngol
. 2024 Nov;
282(2):907-917.
PMID: 39604555
Objective: To assess the opinion, practices, and challenges of international key opinion leaders about two minimal invasive surgical techniques in supraglottic laryngeal tumours: transoral laser microsurgery (TLM) and the transoral...
5.
Pazdrowski J, Gornowicz-Porowska J, Kazmierska J, Krajka-Kuzniak V, Polanska A, Masternak M, et al.
Rep Pract Oncol Radiother
. 2024 Aug;
29(3):373-390.
PMID: 39144266
Worldwide increase of head and neck cancers ranks these malignancies among top causes of cancer in human population. Radiation induced skin injury (RISI) is one of the major side effects...
6.
Wojtera B, Ostrowska K, Szewczyk M, Masternak M, Golusinski W
Rep Pract Oncol Radiother
. 2024 Aug;
29(2):258-270.
PMID: 39143969
Background: The chloride intracellular channels (CLICs) family includes six ion channels (CLIC1-CLIC6) expressed on the cellular level and secreted into interstitial fluid and blood. They are involved in the physiological...
7.
Pazdrowski J, Szewczyk M, Pazdrowski P, Seraszek-Jaros A, Niewinski P, Golusinski W
Rep Pract Oncol Radiother
. 2024 Aug;
29(2):204-210.
PMID: 39143967
Background: The behavior of cutaneous squamous cell carcinoma (cSCC) of the head and neck remains poorly understood. There is much controversy regarding the risk of local and nodal recurrences, as...
8.
Mackowiak B, Ostrowska K, Kulcenty K, Kazmierska J, Ostapowicz J, Nowicka H, et al.
Rep Pract Oncol Radiother
. 2024 Aug;
29(2):148-154.
PMID: 39143964
Background: Head and neck squamous carcinoma (HNSC) is the sixth most common neoplasm, with a 40-50% overall survival rate. HNSC standard treatment depends on tumor size, metastasis or human papillomavirus...
9.
Ostapowicz J, Ostrowska K, Golusinski W, Kulcenty K, Suchorska W
Adv Med Sci
. 2024 Jul;
69(2):368-376.
PMID: 39047970
Hypoxia in the tumor core negatively affects the outcome of patients with head and neck squamous cell carcinoma (HNSCC). Nevertheless, its role in predicting treatment response requires further exploration. Typically,...
10.
Ostrowska K, Rawluszko-Wieczorek A, Ostapowicz J, Suchorska W, Golusinski W
Front Oncol
. 2024 Jul;
14:1402126.
PMID: 38966069
Background: RNA methyltransferase-like 3 (METTL3) is responsible for methyl group transfer in the progression of -methyladenosine (mA) modification. This epigenetic feature contributes to the structural and functional regulation of RNA...